Discovery: Chromosomes Found To End In Big Loops

May 14, 1999

CHAPEL HILL - Scientists at the University of North Carolina at Chapel Hill's Lineberger Comprehensive Cancer Center and Rockefeller University appear to have solved an important and long-standing mystery in cell biology. The puzzle is why cells' internal repair machinery doesn't mistake the ends of chromosomes for broken DNA and either "fix" or destroy them.

Working together, the researchers have discovered that mammals' chromosomes end in loops. Under intense magnification, those chromosome ends, or telomeres, look something like lassos.

A report on the findings appears as the cover story in the May 14 issue of the journal Cell. Lead authors are Drs. Jack Griffith, professor of microbiology and immunology at the UNC-CH School of Medicine, and Titia de Lange, professor and head of Rockefeller's Laboratory of Cell Biology and Genetics.

"We think this work is highly important because it should provide a whole new way of thinking about basic molecular mechanisms related to cancer and to control of aging in cells," Griffith said.

Genetic information in cells is stored in 46 long thread-like molecules called DNA, and each is packaged into a rod-shaped structure called a chromosome, he explained. When cells are exposed to X rays or other insults that break DNA molecules, the repair mechanisms stitch the broken ends back together. If too many breaks occur, then a cellular suicide response kicks in, and cells die.

"The question has been why natural chromosome ends, of which there are 92 per cell, do not trigger that response," the scientist said. "We believe we've found the answer."

For the first time, the researchers have produced photographs that show the loops clearly.

"The first clue came from studies by Dr. de Lange's group of one of the proteins they had discovered," said Griffith, whose laboratory employs electron microscopes to investigate the architecture of DNA molecules. "When this particular protein was functionally removed from the cell, the cell suicide response was triggered, which implicated the protein in masking the chromosome ends."

That finding encouraged the Rockefeller and UNC-CH teams to carry out experiments to examine how the protein might arrange DNA molecules containing genetic sequences typical of telomeres, he said. Resulting electron microscope images showed DNA molecules arranged into the lasso-like structures.

"DNA typical of the chromosome end, or telomere, was looped back around and attached to a distant internal site on the DNA and held there by the added protein," Griffith said. "The loop thus formed disguised the DNA end, keeping it cloaked or hidden from the sensors that trigger the cell suicide response."

Researchers then clipped DNA away from the ends of both human and mouse chromosomes, revealing very large loops, he said. While those structures appeared huge in photographs, they measured only 1/3000th of an inch around and comprised only 1/1000th of the chromosomes' total DNA.

Because chromosomes shorten as people age, many scientist believe telomeres play some unexplained central role in the body's lifelong biologic clock, Griffith said. Thus, telomeres may be some kind of regulator of cell death.

"Very rarely these days in science does a new result emerge from ongoing research, loop around, bite you from behind and make you say - Hey!" wrote Dr. Carol Greider of Johns Hopkins University in an accompanying editorial in Cell. "But this is just what has happened in the telomere field... .These results will make us re-think the classical view of telomere function that has emerged over the past 20 years and give a context in which a new synthesis will emerge."

The National Institutes of Health supported the research at both laboratories.
-end-


University of North Carolina at Chapel Hill

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.